Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01696981 · ClinicalTrials.gov registry record · NA
Screening for Colorectal Cancer in Older Patients (PLCO Screening Trial)
A NA study of Colon Carcinoma and Rectal Carcinoma, sponsored by National Cancer Institute (NCI).
- Active
- Registry status
- NA
- Development phase
- 154,900
- Enrollment target
- 1
- Study location
NCT01696981: Active NA study of Colon Carcinoma and Rectal Carcinoma, sponsored by National Cancer Institute (NCI).
NCT01696981 is a NA study of Colon Carcinoma and Rectal Carcinoma that is active but no longer recruiting, run by National Cancer Institute (NCI). The registered enrollment target is 154,900 participants, above the 968-participant average among 7 other Colon Carcinoma trials with a reported enrollment target (15902% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01696981, a NA study of Colon Carcinoma and Rectal Carcinoma, is active but no longer recruiting, sponsored by National Cancer Institute (NCI).
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 154,900 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial studies whether screening methods used to diagnose cancer of the prostate, lung, colon, rectum, or ovaries can reduce deaths from these cancers. Screening tests may help doctors find cancer cells early and plan better treatment for colorectal cancer.
Primary Outcome
Colorectal cancer deaths confirmed in participants by a death review committee if available, otherwise by death certificate.
Conditions Studied
Interventions
- OTHER Screening Questionnaire Administration
- PROCEDURE Sigmoidoscopy
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154,900 participants |
| Start Date | 1993-11-16 |
| Est. Completion | 2026-03-25 |
| Phase | NA |
What the registry record for NCT01696981 still lists
NCT01696981 is an interventional study that assigns participants to a tested intervention. Its 154,900 participants enrollment target places it among the larger protocols in the corpus, above the 968-participant average among 7 other Colon Carcinoma trials with a reported enrollment target (15902% higher).
The record links to 2 conditions, with Colon Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which Screening Questionnaire Administration is the first listed.
NCT01696981 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT01696981 about?
NCT01696981 is a clinical study titled "Screening for Colorectal Cancer in Older Patients (PLCO Screening Trial)". This clinical trial studies whether screening methods used to diagnose cancer of the prostate, lung, colon, rectum, or ovaries can reduce deaths from these cancers. Screening tests may help doctors find cancer cells early and plan better treatment for colorectal cancer.
What is the current status of trial NCT01696981?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 154,900 participants. The study started on 1993-11-16. Estimated completion is 2026-03-25.
What conditions does trial NCT01696981 study?
This clinical trial studies the following conditions: Colon Carcinoma, Rectal Carcinoma.
What interventions are being tested in trial NCT01696981?
The interventions under investigation include: Screening Questionnaire Administration (OTHER), Sigmoidoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT01696981?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01696981 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colon Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lesion Detection Assessment in the Liver: Standard vs Low Radiation Dose Using Varied Post-Processing Techniques
ACTIVE NOT RECRUITING · NA
-
Clinical Outcomes for Offering Genetic Testing in a Tiered Approach
COMPLETED · NA
-
Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
RECRUITING · Phase 2
-
Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy
ACTIVE NOT RECRUITING · Phase 1
-
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
ACTIVE NOT RECRUITING · Phase 2
-
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
ACTIVE NOT RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06917339 · 156,000 participants
Retrospective Analyses of TrakStar Database
- NCT06232551 · 152,000 participants · NA
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
- NCT05994482 · 130,000 participants
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study
- NCT06090578 · 180,000 participants · NA
TabCAT Brain Health Assessment in Primary Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI